Abstract:Epilepsy Currents, Ahead of Print. Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed Epilepsy Hakeem H, Feng W, Chen Z, Choong J, Brodie MJ, Fong SL, Lim KS, Wu J, Wang X, Lawn N, Ni G. JAMA Neurol. 2022;79(10):986-996. doi:10.1001/jamaneurol.2022.2514 Importance:Selection of antiseizure medications (ASMs) for epilepsy remains largely a trial-and-error approach. Under this approach, many patients have to endure sequential trials of ineffective treatments until the "right drugs" are prescribed.Objective:To develop and validate a deep learning model using readily available clinical information to predict treatment success with the first ASM for individual patients.Design, Setting, and Participants:This cohort study developed and validated a prognostic model. Patients were treated between 1982 and 2020. All patients were followed up for a minimum of 1 year or until failure of the first ASM. A total of 2404 adults with epilepsy newly treated at specialist clinics in Scotland, Malaysia, Australia, and China between 1982 and 2020 were considered for inclusion, of whom 606 (25.2%) were excluded from the final cohort because of missing information in 1 or more variables.Exposures:One of 7 antiseizure medications.Main Outcomes and Measures:With the use of the transformer model architecture on 16 clinical factors and ASM information, this cohort study first pooled all cohorts for model training and testing. The model was trained again using the largest cohort and externally validated on the other 4 cohorts. The area under the receiver operating characteristic curve (AUROC), weighted balanced accuracy, sensitivity, and specificity of the model were all assessed for predicting treatment success based on the optimal probability cutoff. Treatment success was defined as complete seizure freedom for the first year of treatment while taking the first ASM. Performance of the transformer model was compared with other machine learning models.Results:The final pooled cohort included 1798 adults (54.5% female; median age, 34 years [IQR, 24-50 years]). The transformer model that was trained using the pooled cohort had an AUROC of 0.65 (95% CI, 0.63-0.67) and a weighted balanced accuracy of 0.62 (95% CI, 0.60-0.64) on the test set. The model that was trained using the largest cohort only had AUROCs ranging from 0.52 to 0.60 and a weighted balanced accuracy ranging from 0.51 to 0.62 in the external validation cohorts. Number of pretreatment seizures, presence of psychiatric disorders, electroencephalography, and brain imaging findings were the most important clinical variables for predicted outcomes in both models. The transformer model that was developed using the pooled cohort outperformed 2 of the 5 other models tested in terms of AUROC.Conclusions and Relevance:In this cohort study, a deep learning model showed the feasibility of personalized prediction of response to ASMs based on clinical information. With improvement of performance, such as by incorporating genetic and imaging data, this model may potentially assist clinicians in selecting the right drug at the first trial.

Prediction of antiepileptic drug treatment outcomes of patients with newly diagnosed epilepsy by machine learning

Prediction of antiepileptic drug treatment outcomes using machine learning

Predicting cognitive impairment in outpatients with epilepsy using machine learning techniques

Machine learning models for predicting treatment response in infantile epilepsies

Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed Epilepsy

Predicting efficacy of antiseizure medication treatment with machine learning algorithms in North Indian population

Machine Learning Techniques for Predicting the Short-Term Outcome of Resective Surgery in Lesional-Drug Resistance Epilepsy

Models for predicting treatment efficacy of antiepileptic drugs and prognosis of treatment withdrawal in epilepsy patients

Enhancing Epileptic Seizure Prediction with Machine Learning and EEG Analysis

Machine Learning for Predicting Epileptic Seizures Using EEG Signals: A Review

Comparison between epileptic seizure prediction and forecasting based on machine learning

Using Machine Learning to Predict Antidepressant Treatment Outcome from Electronic Health Records

Epileptic Seizure Prediction in Scalp EEG Using an Improved HIVE-COTE Model

Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy

Using machine learning approach to predict depression and anxiety among patients with epilepsy in China: A cross-sectional study

Using Deep Learning and Machine Learning to Detect Epileptic Seizure with Electroencephalography (EEG) Data

Machine-learning for the prediction of one-year seizure recurrence based on routine electroencephalography

Deep Thoughts—Predicting Initial Treatment Response in Newly Diagnosed Epilepsy

Advancing Epilepsy Disease Classification through Machine Learning and Deep Learning Models Utilizing EEG Data.

Machine learning algorithm for predicting seizure control after temporal lobe resection using peri-ictal electroencephalography

Development and Validation of Machine Learning Models for Prediction of Seizure Outcome After Pediatric Epilepsy Surgery